Paper Details

  1. Home
  2. Paper Details

[Clinical aspects of treatment and preventive treatment with thrombocyte aggregation inhibitors in cerebrovascular diseases].

Author: DeeckeL, KolleggerH, OderW, ZeilerK

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Inhibitors of thrombocyte aggregation are commonly used in the therapy and prophylaxis of ischemic cerebrovascular disease. Acetylsalicylic acid is the most studied drug, with proven effectiveness, particularly in males. A daily dose of 300-325 mg is recommended for prophylaxis, with low risk of severe gastrointestinal side effects.
Paper Details　
Original Abstract of the Article :
Inhibitors of thrombocyte aggregation are generally accepted in the therapy and prophylaxis of ischemic cerebrovascular disease. The frequency of re-infarction, morbidity and mortality after TIA, PRIND and minor stroke is influenced favourably. There are controversial opinions, however, about the us...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2516954

データ提供：米国国立医学図書館（NLM）

Clinical Aspects of Thrombocyte Aggregation Inhibitors in Cerebrovascular Diseases

This article explores the clinical use of thrombocyte aggregation inhibitors in the treatment and prevention of cerebrovascular diseases. The authors discuss the benefits of these inhibitors in reducing the risk of re-infarction, morbidity, and mortality after transient ischemic attack (TIA), partial ischemic stroke (PRIND), and minor stroke. They also examine their role in managing more complex cases, such as progressive stroke, cerebral embolism of cardiac origin, and thrombosis of sinuses or cerebral veins.

Navigating the Desert of Cerebrovascular Disease: Thrombocyte Aggregation Inhibitors

This article highlights the crucial role of thrombocyte aggregation inhibitors in managing cerebrovascular diseases. These medications help prevent the formation of blood clots that can lead to stroke and other complications. It's like providing a protective barrier in the harsh desert of cerebrovascular disease, minimizing the risk of dangerous storms.

Understanding the Desert Landscape: A Comprehensive Approach to Stroke Prevention

This article emphasizes the importance of a multifaceted approach to stroke prevention and treatment. It's like understanding the complex and diverse landscape of the desert, identifying key risks and developing strategies to mitigate them. While thrombocyte aggregation inhibitors play a significant role, other measures, such as lifestyle modifications and regular medical checkups, are equally crucial in managing cerebrovascular diseases.

Dr.Camel's Conclusion

This article reviews the clinical use of thrombocyte aggregation inhibitors in cerebrovascular diseases. These inhibitors can significantly reduce the risk of stroke and other complications. It's like having a reliable camel caravan in the desert of cerebrovascular disease, ensuring a safe and smooth journey through this potentially dangerous landscape.

Date :
  1. Date Completed 1990-04-13
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2516954

DOI: Digital Object Identifier

2516954

Related Literature

Article Analysis
・Side Effects of sulfinpyrazone
SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.